Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

ClinicalTrials.gov ID: NCT04842747

Public ClinicalTrials.gov record NCT04842747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 9:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate the efficacy of VERU-111 in the treatment of SARS-Cov-2 Infection by assessing its effect on the proportion of patients who die on study (prior to Day 60).

Study identification

NCT ID
NCT04842747
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Veru Inc.
Industry
Enrollment
204 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 18, 2021 (Actual)
Primary completion
Jul 6, 2022 (Actual)
Completion
Jul 6, 2022 (Actual)
Last update posted
Sep 10, 2026

2021 – 2022

United States locations

U.S. sites
21
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Honor Health Scottsdale Arizona 85258 —
St. Bernard's Medical Center Jonesboro Arkansas 72401 —
Velocity Clinical Research Chula Vista California 91911 —
Velocity Clinical Research - San Diego La Mesa California 91942 —
Westchester General Hospital, Research Department Miami Florida 33155 —
James A. Haley Veterans Hospital Tampa Florida 33612 —
Wellstar Research Institute Marietta Georgia 30060 —
Benchmark Research Covington Louisiana 70433 —
Methodist Hospital Saint Louis Park Minnesota 55426 —
Regions Hospital Saint Paul Minnesota 55426 —
Inspira Medical Center Mullica Hill Mullica Hill New Jersey 08062 —
Holy Name Medical Center, Institute for Clinical Research Teaneck New Jersey 07666 —
Inspira Medical Center Vineland New Jersey 08360 —
University of North Carolina Chapel Hill North Carolina 27514 —
Atrium Health Carolinas Medical Center Charlotte North Carolina 28203 —
The Stern Cardiovascular Foundation, Inc. Germantown Tennessee 38138 —
Regional One Health Memphis Tennessee 38103 —
North Knoxville Medical Center Powell Tennessee 37849 —
HD Research (Memorial Hermann - Memorial City Medical Center) Houston Texas 77024 —
HD Research (Memorial Hermann Southeast Hospital) Houston Texas 77024 —
Clinical Trial Network Houston Texas 77074 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04842747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04842747 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →